Inserm Transfert Initiative is a private equity general partner firm headquartered in Paris, France.
Switzerland-based biotech company Therachon has raised an additional $5m in Series A from Versant Ventures and others.
Therachon, a developer of treatments for achondroplasia, secured $35m in Series A funding from NEA, OrbiMed, Versant Ventures and others.
Sensorion, a biotech firm that focuses on treating inner ear diseases, received €4m in funding from Innobio and Inserm Transfert Initiative.
Read more news concerning Inserm Transfert Initiative
A sampling of Inserm Transfert Initiative portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?